stockrowHims & Hers Health, Inc. (HIMS) vs Lantheus Holdings, Inc. (LNTH)
- Hims & Hers Health, Inc. HIMS 24.11 −9.56%
- Lantheus Holdings, Inc. LNTH 100.76 −0.38%
Hims & Hers Health, Inc. and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Lantheus Holdings, Inc. is the larger, with a market value of $6.6B against $5.6B — 1.2× the size. Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Lantheus Holdings, Inc. trades at 24.3×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 2.38%. Lantheus Holdings, Inc. has the higher net margin (17.3% vs −5.51%) and the higher return on invested capital (14.6% vs −11.4%). Across the 19 metrics below, Lantheus Holdings, Inc. leads on 13 and Hims & Hers Health, Inc. on 6.
Valuation
Profitability
| Metric | HIMS | LNTH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 68.43% | 61.26% | 53.51% |
| Operating margin | (5.99%) | 18.62% | 0.00% |
| Net margin | (5.51%) | 17.28% | (2.45%) |
| Free cash flow margin | 3.22% | 26.21% | 0.00% |
| Return on equity | (32.03%) | 21.81% | (0.80%) |
| Return on assets | (5.16%) | 11.41% | (1.67%) |
| Return on invested capital | (11.38%) | 14.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack